BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24471414)

  • 1. Large equatorial ligand effects on C-H bond activation by nonheme iron(IV)-oxo complexes.
    Sun X; Geng C; Huo R; Ryde U; Bu Y; Li J
    J Phys Chem B; 2014 Feb; 118(6):1493-500. PubMed ID: 24471414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of an alternative to the H-atom abstraction mechanism in methane C-H bond activation by nonheme iron(IV)-oxo oxidants.
    Tang H; Guan J; Liu H; Huang X
    Dalton Trans; 2013 Jul; 42(28):10260-70. PubMed ID: 23732441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the axial ligand on distinct reaction tunneling for methane hydroxylation by nonheme iron(IV)-oxo complexes.
    Tang H; Guan J; Zhang L; Liu H; Huang X
    Phys Chem Chem Phys; 2012 Oct; 14(37):12863-74. PubMed ID: 22890313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivity of compound II: electronic structure analysis of methane hydroxylation by oxoiron(IV) porphyrin complexes.
    Rosa A; Ricciardi G
    Inorg Chem; 2012 Sep; 51(18):9833-45. PubMed ID: 22946694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative insight into electronic properties and reactivities toward C-H bond activation by iron(IV)-nitrido, iron(IV)-oxo, and iron(IV)-sulfido complexes: a theoretical investigation.
    Tang H; Guan J; Liu H; Huang X
    Inorg Chem; 2013 Mar; 52(5):2684-96. PubMed ID: 23425218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonheme oxo-iron(IV) intermediates form an oxyl radical upon approaching the C-H bond activation transition state.
    Ye S; Neese F
    Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1228-33. PubMed ID: 21220293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuning reactivity and mechanism in oxidation reactions by mononuclear nonheme iron(IV)-oxo complexes.
    Nam W; Lee YM; Fukuzumi S
    Acc Chem Res; 2014 Apr; 47(4):1146-54. PubMed ID: 24524675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced reactivities of iron(IV)-oxo porphyrin pi-cation radicals in oxygenation reactions by electron-donating axial ligands.
    Kang Y; Chen H; Jeong YJ; Lai W; Bae EH; Shaik S; Nam W
    Chemistry; 2009 Oct; 15(39):10039-46. PubMed ID: 19697378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the ruthenium analogue of compound I of cytochrome p450 an efficient oxidant? A theoretical investigation of the methane hydroxylation reaction.
    Sharma PK; De Visser SP; Ogliaro F; Shaik S
    J Am Chem Soc; 2003 Feb; 125(8):2291-300. PubMed ID: 12590559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axial ligand tuning of a nonheme iron(IV)-oxo unit for hydrogen atom abstraction.
    Sastri CV; Lee J; Oh K; Lee YJ; Lee J; Jackson TA; Ray K; Hirao H; Shin W; Halfen JA; Kim J; Que L; Shaik S; Nam W
    Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19181-6. PubMed ID: 18048327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electronic structure analysis of multistate reactivity in transition metal catalyzed reactions: the case of C-H bond activation by non-heme iron(IV)-oxo cores.
    Ye S; Geng CY; Shaik S; Neese F
    Phys Chem Chem Phys; 2013 Jun; 15(21):8017-30. PubMed ID: 23632340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in substrate hydroxylation reactions by heme and nonheme iron(IV)-oxo oxidants give correlations between intrinsic properties of the oxidant with barrier height.
    de Visser SP
    J Am Chem Soc; 2010 Jan; 132(3):1087-97. PubMed ID: 20041691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear Resonance Vibrational Spectroscopic Definition of the Facial Triad Fe
    Srnec M; Iyer SR; Dassama LMK; Park K; Wong SD; Sutherlin KD; Yoda Y; Kobayashi Y; Kurokuzu M; Saito M; Seto M; Krebs C; Bollinger JM; Solomon EI
    J Am Chem Soc; 2020 Nov; 142(44):18886-18896. PubMed ID: 33103886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axial vs. Equatorial Ligand Rivalry in Controlling the Reactivity of Iron(IV)-Oxo Species: Single-State vs. Two-State Reactivity.
    Kumar R; Ansari A; Rajaraman G
    Chemistry; 2018 May; 24(26):6818-6827. PubMed ID: 29504691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxylation catalysis by mononuclear and dinuclear iron oxo catalysts: a methane monooxygenase model system versus the Fenton reagent Fe(IV)O(H2O)5(2+).
    Gopakumar G; Belanzoni P; Baerends EJ
    Inorg Chem; 2012 Jan; 51(1):63-75. PubMed ID: 22221279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An abiotic analogue of the diiron(IV)oxo "diamond core" of soluble methane monooxygenase generated by direct activation of O2 in aqueous Fe(II)/EDTA solutions: thermodynamics and electronic structure.
    Bernasconi L; Belanzoni P; Baerends EJ
    Phys Chem Chem Phys; 2011 Sep; 13(33):15272-82. PubMed ID: 21776512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How does tunneling contribute to counterintuitive H-abstraction reactivity of nonheme Fe(IV)O oxidants with alkanes?
    Mandal D; Ramanan R; Usharani D; Janardanan D; Wang B; Shaik S
    J Am Chem Soc; 2015 Jan; 137(2):722-33. PubMed ID: 25513834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic insights on the ortho-hydroxylation of aromatic compounds by non-heme iron complex: a computational case study on the comparative oxidative ability of ferric-hydroperoxo and high-valent Fe(IV)═O and Fe(V)═O intermediates.
    Ansari A; Kaushik A; Rajaraman G
    J Am Chem Soc; 2013 Mar; 135(11):4235-49. PubMed ID: 23373840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insight into the electronic structure of iron(IV)-oxo porphyrin compound I. A quantum chemical topological analysis.
    Viciano I; Berski S; Martí S; Andrés J
    J Comput Chem; 2013 Apr; 34(9):780-9. PubMed ID: 23233452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling TauD-J: a high-spin nonheme oxoiron(IV) complex with high reactivity toward C-H bonds.
    Biswas AN; Puri M; Meier KK; Oloo WN; Rohde GT; Bominaar EL; Münck E; Que L
    J Am Chem Soc; 2015 Feb; 137(7):2428-31. PubMed ID: 25674662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.